Researchers reported that a significant percentage of subjects ceased their use of prescription opioids by the conclusion of the trial.
Archives: News Releases
Since 1992, every Thursday and when breaking news warrants, NORML | The NORML Foundation have been issuing weekly press releases for marijuana law supporters and the media.
NORML’s News Releases archives goes back to 1996 and serves as a valuable tool to alert citizens about cannabis-related news and legislation as well as a research tool for reviewing a chronology of marijuana law reform.
Investigators concluded, "Our findings support the literature in that medical cannabis reduces the use of opioids for the treatment of chronic pain."
In all, the agency identified 553 banks and 202 credit unions that are "actively providing banking services to marijuana-related businesses."
Adult use sales first began in mid-January. By November, monthly sales of adult-use products exceeded those of medical cannabis.
Subjects in the study appeared "to recover almost back to baseline levels 1-hour post-use."
Those who filled their cannabis extract prescriptions three times or more during the study period decreased their use of prescription opioids.
“Results showed … a high rate of effectiveness in the prescribed treatment, as well as a decrease in pain levels, improvement in QOL, and a reduction in the consumption of concomitant medications.”
The studies’ findings add to the growing body of literature establishing that various formulations of cannabis and cannabinoids safely and effectively mitigate hard-to-treat pain conditions.